본문 바로가기
KERD
논문KCI 등재

우울증의 진단 및 평가 지침 개발 : 평가 지침을 중심으로

Development of Clinical Guideline for the Diagnosis and Evaluation of Depression : Focused on Evaluation Guideline

구본훈|조현주|김민경|사공정규|성형모|이준엽|김대현|김정범|김양태|정성원|신임희|문은수|최정식|정인명
대한신경정신의학회 (Korean Neuropsychiatric Association)|2014.01|신경정신의학 (JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION)|제53권 제1호|pp. 24-31

0

조회

0

다운로드

6

인용

0

참고문헌

키워드

평가EvaluationDepression우울장애진단DiagnosisClinical practice guidelineDepressive disorder임상진료지침우울증
주제분류정신과학

초록

우울증의 진단시 우울증의 유무를 넘어 우울증의 치료반응이나 경과에 영향을 줄 수 있는 특성에 대한 자세한 평가가필요하다. 본 평가 지침에서는 진단아형이나 증상의 심각도,자살경향성, 정신과적 동반질환, 신체질환 동반유무 등을 함께 평가할 것을 권고한다(권고등급 B).

Abstract

Objectives The aim of this study is to develop guideline for evaluation of depression. Methods Development of this guideline was processed according to the ADAPTE manual,which was developed for adaptation of good clinical practice guidelines. Important key questionswere determined, and a systematic review of clinical practice guidelines was performed. Thecontents of guidelines selected by comparison of the methodological quality and currency wereevaluated with regard to the applicability and acceptability. Answers to key questions and clinicalrecommendations were established by peer review. Results Careful evaluations on the characteristics of depression, including subtype, severity,suicidality, and psychiatric and physical comorbidities were recommended because these factorscan have an influence on course and prognosis in treatment of depression. Conclusion The results of this study may contribute to the systematic evaluation of depression,based on clinical importance. However, this guideline did not include systematic reviewsregarding useful scales for evaluation of depression. In the future, amendment of this guidelinemight be needed in order to supplement limitations.

참고문헌 (50)

  1. Chen L, "Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors:a longitudinal, population-based study", J Affect Disord, 59, pp.1~11 (2000)
  2. Merikangas KR, "Heterogeneity of depression. Classification of depressive subtypes by longitudinal course", Br J Psychiatry, 164, pp.342~348 (1994)
  3. Terao T., "Diagnosis and severity assessment of patients with depression", Nihon Rinsho, 65, pp.1614~1618 (2007)
  4. Davis LL, "Substance use disorder comorbidity in major depressive disorder:a confirmatory analysis of the STAR*D cohort", Am J Addict, 15, pp.278~285 (2006)
  5. Farabaugh A, "Relationships between major depressive disorder and comorbid anxiety and personality disorders", Compr Psychiatry, 46, pp.266~271 (2005)
  6. Egede LE, "Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes", Psychosom Med, 67, pp.46~51 (2005)
  7. Kozhimannil KB, "Association between diabetes and perinatal depression among low-income mothers", JAMA, 301, pp.842~847 (2009)
  8. Hall RC, "Thyroid disease and abnormal thyroid function tests in women with eating disorders and depression", J Fla Med Assoc, 82, pp.187~192 (1995)
  9. Pagliaro LA, "Cocaine use and depression", CMAJ, 147, pp.1636~1637 (1992)
  10. Ros LT, "Symptomatic depression after long-term steroid treatment: a case report", Afr J Med Med Sci, 33, pp.263~265 (2004)
  11. Bostwick JM, "Affective disorders and suicide risk: a reexamination", Am J Psychiatry, 157, pp.1925~1932 (2000)
  12. Dorpat TL, "A study of suicide in the Seattle area", Compr Psychiatry, 1, pp.349~359 (1960)
  13. Beautrais AL, "Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study", Am J Psychiatry, 153, pp.1009~1014 (1996)
  14. Roy A., "Depression, attempted suicide, and suicide in patients with chronic schizophrenia", Psychiatr Clin North Am, 9, pp.193~206 (1986)
  15. Kim SY, "Manual for Guideline Adaptation Ver 2.0" (2011), National Evidencebased Healthcare Collaborating Agency
  16. ICSI Health Care Guideline Working Group, "Institude for Clinical System Improvement (ICSI) Health Care Guideline: Major Depression in Adults in Primary Care" (2011), Institute for Clinical Systems Improvement, Inc
  17. Kennedy SH, "Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction", J Affect Disord, 117(Suppl 1), pp.S1~S2 (2009)
  18. National Institute for Health and Clinical Excellence, "Depression: the Treatment and Management of Depression in Adults" (2009), National Institute for Health and Clinical Excellence
  19. New Zealand Guidelines Group, "Identification of Common Mental Disorders and Management of Depression in Primary Care. An Evidence-based Best Practice Guideline", New Zealand Guidelines Group, ~ (2008)
  20. Uher R, "Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline", J Affect Disord, 132, pp.112~120 (2011)
  21. Fava M, "Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report", Am J Psychiatry, 165, pp.342~351 (2008)
  22. Elkin I, "Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program", J Consult Clin Psychol, 63, pp.841~847 (1995)
  23. Khan A, "Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database", J Clin Psychopharmacol, 22, pp.40~45 (2002)
  24. Hirschfeld RM, "Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine", J Clin Psychiatry, 59, pp.669~675 (1998)
  25. Schmitt AB, "Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity", Eur Arch Psychiatry Clin Neurosci, 259, pp.329~339 (2009)
  26. Friedman ES, "Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial", Eur Neuropsychopharmacol, 22, pp.183~199 (2012)
  27. Claassen CA, "Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial", J Affect Disord, 97, pp.77~84 (2007)
  28. Kennedy SH, "Canadian Network for Mood and Anxiety Treatments (CANMAT)Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies", J Affect Disord, 117(Suppl 1), pp.S44~S53 (2009)
  29. American Psychiatric Association, "Practice Guideline for the Treatment of Patients With Major Depressive Disorder" (2010), American Psychiatric Association
  30. Mueller TI, "Prognostic effect of the variable course of alcoholism on the 10-year course of depression", Am J Psychiatry, 151, pp.701~706 (1994)
  31. Fraguas R Jr, "Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study", Psychosomatics, 48, pp.418~425 (2007)
  32. Yates WR, "Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis", Prim Care Companion J Clin Psychiatry, 9, pp.7~15 (2007)
  33. Jiang W, "Antidepressant therapy in patients with ischemic heart disease", Am Heart J, 150, pp.871~881 (2005)
  34. Austin MP, "Cognitive function in depression: a distinct pattern of frontal impairment in melancholia?", Psychol Med, 29, pp.73~85 (1999)
  35. Schotte CK, "Cluster analytic validation of the DSM melancholic depression. The threshold model: integration of quantitative and qualitative distinctions between unipolar depressive subtypes", Psychiatry Res, 71, pp.181~195 (1997)
  36. Yang SJ, "Response to antidepressants in major depressive disorder with melancholic features: the CRESCEND study", J Affect Disord, 144, pp.42~50 (2013)
  37. Kim JM, "Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study", Hum Psychopharmacol, 26, pp.41~50 (2011)
  38. Seo HJ, "Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression", J Nerv Ment Dis, 199, pp.42~48 (2011)
  39. van der Lem R, "The generalizability of antidepressant efficacy trials to routine psychiatric outpatient practice", Psychol Med, 41, pp.1353~1363 (2011)
  40. Brådvik L, "Long-term suicide risk of depression in the Lundby cohort 1947-1997--severity and gender", Acta Psychiatr Scand, 117, pp.185~191 (2008)
  41. Isometsä ET, "Suicide in major depression", Am J Psychiatry, 151, pp.530~536 (1994)
  42. 조맹제, "한국 주요정신장애의 유병률 및 관련요인：2006 전국정신질환역학조사", 신경정신의학, 48(3), pp.143~152 (2009), 대한신경정신의학회
  43. Jeon HJ, "Lifetime prevalence and correlates of suicidal ideation, plan, and single and multiple attempts in a Korean nationwide study", J Nerv Ment Dis, 198, pp.643~646 (2010)
  44. Park MH, "Clinical characteristics of depressed patients with a history of suicide attempts:results from the CRESCEND study in South Korea", J Nerv Ment Dis, 198, pp.748~754 (2010)
  45. Kim SW, "Relationship between a history of a suicide attempt and treatment outcomes in patients with depression", J Clin Psychopharmacol, 31, pp.449~456 (2011)
  46. McIntyre RS, "The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders", Ann Clin Psychiatry, 24, pp.69~81 (2012)
  47. 정지원, "주요우울증에서 자살경향성 : 공존질환의 영향", 신경정신의학, 51(2), pp.85~92 (2012), 대한신경정신의학회
  48. Kim JM, "Physical comorbidity and 12-week treatment outcomes in Korean patients with depressive disorders: the CRESCEND study", J Psychosom Res, 71, pp.311~318 (2011)
  49. Lichtman JH, "Depression and coronary heart disease:recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association", Circulation, 118, pp.1768~1775 (2008)
  50. Morris DW, "Measurement-based care for unipolar depression", Curr Psychiatry Rep, 13, pp.446~458 (2011)

관련 논문AI추천

우울증 관련 평가도구의 개관전태연, 조현주, 채정호대한신경정신의학회 · 신경정신의학2007 · 제46권 제2호우울증의 진단 및 평가 지침 개발 : 진단 지침을 중심으로구본훈, 김대현, 김민경, 김양태, 김정범, 문은수, 성형모, 신임희, 이준엽, 정성원, 정인명, 조현주, 최정식, 사공정규대한신경정신의학회 · 신경정신의학2014 · 제53권 제1호한국형 우울증 진료지침 개발및 적용연구-우울증 진료지침 개발의 국내외 현황과 개발방향-이민수, 임세원대한생물정신의학회 · 생물정신의학2006 · 제13권 제1호국내 우울증 평가도구 타당화 연구의 체계적 고찰-진단적 타당성을 중점으로 : 한국형 우울 선별 도구 개발을 위한 예비 연구김신향, 박기호, 이승환, 이원혜, 정수연, 최기홍, 최윤영, 제갈은주대한불안의학회 · 대한불안의학회지2017 · 제13권 제2호한국형 우울장애 선별도구의 개발: 예비연구김신향, 박기호, 이승환, 이원혜, 정수연, 최기홍, 최윤영, 제갈은주한국임상심리학회 · Korean Journal of Clinical Psychology2017 · 제36권 제4호한국인의 우울증 진단기준의 특성손지훈, 이동현, 이준영, 장성만, 전홍진, 조맹제, 조성진, 최지환, 함봉진대한신경정신의학회 · 신경정신의학2007 · 제46권 제5호

이 간행물의 다른 논문 (6건)

번개탄을 이용한 자살에 대한 전반적 고찰과 예방 대책이아롱, 홍진표, 안명희, 이태엽, 정수연pp. 1-7학교기반 자살예방 프로그램 : 장점과 제한에 대한 교사의 인식권용실, 권호인, 노법래, 김란, 서은희, 홍현주pp. 8-14우울증의 진단 및 평가 지침 개발 : 진단 지침을 중심으로김정범, 김양태, 정성원, 신임희, 문은수, 최정식, 정인명, 구본훈, 조현주, 김민경, 사공정규, 성형모, 이준엽, 김대현pp. 15-23정신질환자의 인권지표 개발 : 국립병원의 조현병과 양극성장애 환자를 중심으로시영화, 홍창희, 배안, 정성미, 윤보현pp. 32-39집단음악치료가 통원치료 중인 조현병 환자의 사회적 기능과 대인관계에 미치는 영향박민철, 이대보, 이상열, 이혜진pp. 40-53
원문 보기